Search results
- The Sheila Singh Lab research program is dedicated to applying a developmental neurobiology approach to the study of human brain tumours. As a pediatric neurosurgeon, Dr. Singh is acutely aware of the needs of patients and clinicians dealing with these diseases and uses that unique perspective to guide her research questions and areas of focus.
www.sheilasinghlab.ca/
People also ask
Who is Dr Sheila Singh?
Where did Dr Singh get her PhD in neurosurgery?
What degree does Dr Singh have?
Dr. Sheila Singh is a Professor of Surgery and Biochemistry, chief pediatric neurosurgeon at McMaster Children’s Hospital, the Division Head of Neurosurgery at Hamilton Health Sciences, and the inaugural Director of McMaster's new Cancer Research Centre: Centre for Discovery in Cancer Research.
- Sheila Singh Lab
The Sheila Singh Lab is located at McMaster University's...
- Team - sheilasinghlab.ca
These are the passionate and dedicated individuals that are...
- Sheila Singh Lab
The Sheila Singh Lab is located at McMaster University's Cancer Research Centre, in Hamilton, Ontario, Canada. The three types of tumours studied by the Sheila Singh Lab are glioblastoma, medulloblastoma and brain metastases.
Dr Sheila Singh is a Professor of Surgery and Biochemistry, Chief Paediatric Neurosurgeon at McMaster Children’s Hospital, former Division Head of Neurosurgery at Hamilton Health Sciences and inaugural director of the new Cancer Research Centre at McMaster University.
These are the passionate and dedicated individuals that are the face, the heart, the brain, and the soul of the Sheila Singh Lab. They work tirelessly, inspired by the lives of patients. And, together, their efforts are expanding the frontiers of brain cancer research. Sheila Singh, MD, PhD, FRCSC. Principal Investigator.
Singh's lab focuses on understanding the molecular mechanisms that govern BTIC self-renewal, building upon cell culture techniques used for isolating normal neural stem cells (NSC), applying them to brain tumors and developing a xenograft model to study BTIC activity.
Dr. Sheila Singh is a Professor in the Department of Surgery and Biochemistry. She is the Director of the Surgeon-Scientist Program, Director of the Pediatric Brain Tumour Study Group, and the Director of the Centre for Discovery in Cancer Research (CDCR).
Her ultimate goal is to selectively target the BTIC with appropriately tailored drug and molecular therapies. Her laboratory is funded by CCSRI, CIHR, TFRI, CRS, the Stem Cell Network, McMaster Surgical Associates, Brain Canada and the Boris Family Fund.
